China Securities Intelligent Financial News Medicilon (688202) disclosed its third quarter report for 2024 on October 31. In the first three quarters, the company achieved operating income of 802 million yuan, a year-on-year decrease of 32.24%; The net profit loss attributable to the parent company was 129 million yuan, compared with a profit of 115 million yuan in the same period last year, the non-net profit loss was 142 million yuan, the profit in the same period last year was 99.919 million yuan, the net cash flow generated by operating activities was -68.7493 million yuan, compared with -8.769 million yuan in the same period last year, and the basic earnings per share of Medicilon was -0.96 yuan, and the weighted average return on equity was -5.30% during the reporting period.

Based on the closing price on October 30, Medicilon's current price-to-earnings ratio (TTM) is about -17.15x, the price-to-book ratio (LF) is about 2.02x, and the price-to-sales ratio (TTM) is about 4.82x.

In terms of profitability, the company's weighted average return on equity in the first three quarters of 2024 was -5.3%, down 11.83 percentage points year-on-year. The company's return on invested capital in the first three quarters of 2024 was -5.89%, down 10.6 percentage points from the same period last year.

In the first three quarters of 2024, the company's net cash flow from operating activities was -68.7493 million yuan, a year-on-year decrease of 59.9803 million yuan, the net cash flow from financing activities was -129 million yuan, a year-on-year decrease of 1.287 billion yuan, and the net cash flow from investment activities was 85.4367 million yuan, compared with -815 million yuan in the same period last year.

In terms of major changes in assets, as of the end of the third quarter of 2024, the total trading financial assets of the company decreased by 43.54% from the end of the previous year, accounting for 5.94 percentage points of the company's total assets, notes receivable and accounts receivable increased by 9.01% from the end of the previous year, accounting for 3.76 percentage points of the company's total assets, monetary funds decreased by 23.22% from the end of the previous year, accounting for 2.16 percentage points of the company's total assets, and debt investment increased by 53.26% from the end of the previous year. The proportion of the company's total assets increased by 1.74 percentage points.

In terms of major changes in liabilities, as of the end of the third quarter of 2024, the company's short-term borrowings decreased by 24.26% from the end of the previous year, accounting for 1.72 percentage points of the company's total assets, notes payable and accounts payable decreased by 18.18% from the end of the previous year, accounting for 0.55 percentage points of the company's total assets, contract liabilities decreased by 24.77% from the end of the previous year, accounting for 0.32 percentage points of the company's total assets, and taxes payable increased by 181.15% from the end of the previous year. The proportion of the company's total assets increased by 0.32 percentage points.

For the first three quarters of 2024, the company has a current ratio of 2.84 and a quick ratio of 2.64.

The third quarterly report shows that among the top ten circulating shareholders of the company at the end of the third quarter of 2024, the new shareholder is Shi Yijun, replacing He Huiqing at the end of the second quarter. In terms of specific shareholding ratio, the shareholding of Hong Kong Securities Clearing Co., Ltd. has decreased.

Proofreading: Dong Ningning

Indicator Annotation:

P/E ratio = total market capitalization / net profit. When the company loses money, the P/E ratio is negative, and it is not practical to use the P/E ratio for valuation, and the P/B ratio or P/B ratio is often used as a reference.

Price-to-book ratio = total market capitalization / net assets. The price-to-book ratio valuation method is mostly used for companies with large fluctuations in earnings and relatively stable net assets.

Price-to-sales ratio = total market capitalization / operating income. The price-to-sales ratio method is often used for growing companies that are losing money or making small profits.

The price-to-earnings ratio and price-to-sales ratio in this article are calculated using the TTM method, that is, the data for the 12 months up to the latest financial report (including forecast). The price-to-book ratio is calculated using the LF method, that is, based on the latest financial report data. The quantile calculation range of the three is from the company's listing to the latest announcement date.

When the P/E ratio and price-to-book ratio are negative, the current quantile is not displayed, which will cause the line chart to be interrupted.